跳至主要内容
临床试验/KCT0009607
KCT0009607尚未招募Unknown

Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: A prospective multicenter randomized phase III trial (POHIM_P3 trial)

Samsung Medical Center0 个研究点目标入组 284 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
284

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20(Year) 至 75(Year)(—)
性别
Female

入选标准

  • (1) Histologically confirmed cervical cancer
  • (2) Histologically confirmed Squamous cell carcinoma, Adenocarcinoma or Adenosquamous carcinoma
  • (3) Patients who underwent radical hysterectomy and pelvic lymph node dissection
  • (4) Patients with pathological indications for radiotherapy
  • A. Pelvic lymph node metastasis
  • B.Parametrium involvement
  • C.Positive surgical margins
  • (5) Age 20 - 75 years
  • (6) ECOG performance status 0-1
  • (7) Adequate bone marrow function: Granulocytes =1.0 x 103/µl, Platelets =30 x 103/µl, Hemoglobin =9.5 g/dl
  • (8) Adequate renal and liver function (Creatinine <2.0 mg/dL, Bilirubin 1.5 mg/dl)
  • (9) Signed informed consent

排除标准

  • (1) Distant metastasis
  • (2) Previous pelvic radiotherapy
  • (3) More than 3 Months post-radical hysterectomy
  • (4) Untreated serious acute disease without Cervical cancer
  • (5) Nooadjuvant chemotherapy
  • (6) Inability to undergo concurrent chemoradiotherapy
  • (7) History of other cancer within 5 years (except for thyroid cancer, skin cancer, carcinoma in situ)

研究者

相似试验